Pruijn Frederik B, Sturman Joanna R, Liyanage H D Sarath, Hicks Kevin O, Hay Michael P, Wilson William R
Auckland Cancer Society Research Centre, Faculty of Medical and Health Sciences, The University of Auckland, Private Bag 92019, Auckland, New Zealand.
J Med Chem. 2005 Feb 24;48(4):1079-87. doi: 10.1021/jm049549p.
The extravascular diffusion of antitumor agents is a key determinant of their therapeutic activity, but the relationships between physicochemical properties of drugs and their extravascular transport are poorly understood. It is well-known that drug lipophilicity plays an important role in transport across biological membranes, but the net effect of lipophilicity on transport through multiple layers of tumor cells is less clear. This study examines the influence of lipophilicity (measured as the octanol-water partition coefficient P) on the extravascular transport properties of the hypoxic cytotoxin tirapazamine (TPZ, 1) and a series of 13 neutral analogues, using multicellular layers (MCLs) of HT29 human colon carcinoma cells as an in vitro model for the extravascular compartment of tumors. Flux of drugs across MCLs was determined using diffusion chambers, with the concentration-time profile on both sides of the MCL measured by HPLC. Diffusion coefficients in the MCLs (D(MCL)) were inversely proportional to M(r)(0.5) (M(r), relative molecular weight), although this was a minor contributor to differences between compounds over the narrow M(r) range investigated. Differences in lipophilicity had a larger effect, with a sigmoidal dependence of D(MCL) on log P. Correcting for M(r) differences, lipophilic compounds (log P > 1.5) had ca. 15-fold higher D(MCL) than hydrophilic compounds (log P < -1). Using a pharmacokinetic/pharmacodynamic (PK/PD) model in which diffusion in the extravascular compartment of tumors is considered explicitly, we demonstrated that hypoxic cell kill is very sensitive to changes in extravascular diffusion coefficient of TPZ analogues within this range. This study shows that simple monosubstitution of TPZ can alter log P enough to markedly improve extravascular transport and activity against target cells, especially if rates of metabolic activation are also optimized.
抗肿瘤药物的血管外扩散是其治疗活性的关键决定因素,但药物的物理化学性质与其血管外转运之间的关系却鲜为人知。众所周知,药物亲脂性在跨生物膜转运中起重要作用,但亲脂性对穿过多层肿瘤细胞的转运的净效应尚不清楚。本研究以HT29人结肠癌细胞的多细胞层(MCLs)作为肿瘤血管外区室的体外模型,研究亲脂性(以正辛醇-水分配系数P衡量)对缺氧细胞毒素替拉扎明(TPZ,1)及一系列13种中性类似物血管外转运性质的影响。使用扩散室测定药物跨MCLs的通量,通过高效液相色谱法测定MCLs两侧的浓度-时间曲线。MCLs中的扩散系数(D(MCL))与M(r)(0.5)(M(r),相对分子质量)成反比,尽管在所研究的狭窄M(r)范围内,这对化合物之间差异的贡献较小。亲脂性差异的影响更大,D(MCL)对log P呈S形依赖关系。校正M(r)差异后,亲脂性化合物(log P > 1.5)的D(MCL)比亲水性化合物(log P < -1)高约15倍。使用一个明确考虑肿瘤血管外区室扩散的药代动力学/药效学(PK/PD)模型,我们证明在该范围内,缺氧细胞杀伤对TPZ类似物血管外扩散系数的变化非常敏感。本研究表明,TPZ的简单单取代可改变log P,足以显著改善血管外转运及对靶细胞的活性,特别是如果代谢活化速率也得到优化的话。